All In MedTech

FDA Clearance Tracker · P910007-S019

ABBOTT ARCHITECT TOTAL PSA

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Mar 22, 2011 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Mar 22, 2011

Approved

Time to decision

239 days

Received Jul 26, 2010. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P910007-S019
Device name
ABBOTT ARCHITECT TOTAL PSA
Applicant location
Abbott Park, IL
Received
Jul 26, 2010
Decided
Mar 22, 2011
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P910007

Device type

Device class
Class III

Every decision under product code MTF

FDA's approval statement

As written in FDA's record.

APPROVAL FOR MANUFACTURING SITE LOCATED AT ABBOTT IRELAND DIAGSNOSTICS DIVISION IN SLIGO, IRELAND.

Source documents

Other decisions for Abbott Laboratories

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.